Position in BNTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,558,777
+$13,423,570 QoQ
Shares Held
382,147
+53.4% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#29
of 282 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Derivatives in BNTX
reported options exposure · as of Mar 31, 2026CallValue
$257,752
CallShares
2,900
PutValue
$222,200
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. BNTX ranks #27 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in BNTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,558,777 | 382,147 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $222,200 | 2,500 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $22,135,207 | 249,046 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $257,752 | 2,900 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $24,762,185 | 260,107 | Shares | Other | 2026-02-13 | |
| 2025-12-31 | $276,080 | 2,900 | Put | Other | 2026-02-13 | |
| 2025-12-31 | $456,960 | 4,800 | Call | Other | 2026-02-13 | |
| 2025-09-30 | $349,607 | 3,545 | Shares | Other | 2025-11-13 | |
| 2025-09-30 | $295,860 | 3,000 | Put | Other | 2025-11-13 | |
| 2025-09-30 | $483,238 | 4,900 | Call | Other | 2025-11-13 | |
| 2025-06-30 | $515,527 | 4,842 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $23,301,343 | 255,890 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $17,110,389 | 150,157 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $13,418,634 | 112,980 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,891,754 | 35,985 | Shares | Other | 2024-08-14 | |
| 2022-12-31 | $57,443,676 | 382,397 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $19,515,517 | 144,688 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $35,556,174 | 238,472 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $10,711,167 | 62,800 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $43,570,003 | 169,007 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $720,693 | 2,640 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $3,548,565 | 32,499 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,492,305 | 18,306 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $295,391 | 4,426 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||